Extavia (interferon beta-1b): Reviews and patient testimonials


/static/themes-v3/default/images/default/opinion/traitement/intro.jpg?1720004028

Back Back to the list of medications

Medication indications

Extavia

Extavia is indicated for the treatment of:

• Patients with a single demyelinating event with an active inflammatory process, if it is severe enough to warrant treatment with intravenous corticosteroids, if alternative diagnoses have been excluded, and if they are determined to be at high risk of developing clinically definite multiple sclerosis.

• Patients with relapsing remitting multiple sclerosis and two or more relapses within the last two years.

• Patients with secondary progressive multiple sclerosis with active disease, evidenced by relapses.


Molecule: interferon beta-1b

Patients' opinions on Extavia

In brief

General satisfaction level: 7.00/10 Learn more

Treatment's effectiveness: 6.00/10 Learn more

Ease of use: 5.00/10 Learn more

Adherence to prescription: 6.00/10 Learn more

Detected side effects: 7.00/10 Learn more

Improvement in the quality of life: 5.00/10 Learn more

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community

Join Carenity and be the first to give your opinion on this medication.

Conditions related to this medication

Fact sheet

Multiple sclerosis

See the fact sheet